MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning.

Journal: Genome medicine
PMID:

Abstract

Multiple computational approaches have been developed to improve our understanding of genetic variants. However, their ability to identify rare pathogenic variants from rare benign ones is still lacking. Using context annotations and deep learning methods, we present pathogenicity prediction models, MetaRNN and MetaRNN-indel, to help identify and prioritize rare nonsynonymous single nucleotide variants (nsSNVs) and non-frameshift insertion/deletions (nfINDELs). We use independent test sets to demonstrate that these new models outperform state-of-the-art competitors and achieve a more interpretable score distribution. Importantly, prediction scores from both models are comparable, enabling easy adoption of integrated genotype-phenotype association analysis methods. All pre-computed nsSNV scores are available at http://www.liulab.science/MetaRNN . The stand-alone program is also available at https://github.com/Chang-Li2019/MetaRNN .

Authors

  • Chang Li
    Bioengineering College of Chongqing University, Chongqing University Central Hospital (Chongqing Emergency Medical Center), Chongqing, China.
  • Degui Zhi
    School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Kai Wang
    Department of Rheumatology, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
  • Xiaoming Liu
    College of Agriculture, Northeast Agricultural University, Harbin, China.